Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF‐β receptor activation
暂无分享,去创建一个
J. Foidart | A. Noël | C. Munaut | I. Huhtaniemi | S. Blacher | T. Fournier | D. Evain-Brion | S. Berndt | S. P. d’Hauterive | J. Detilleux
[1] L. Cole,et al. Hyperglycosylated hCG, hCGβ and Hyperglycosylated hCGβ: Interchangeable cancer promoters , 2012, Molecular and Cellular Endocrinology.
[2] M. Goumans,et al. Controlling angiogenesis by two unique TGF-β type I receptor signaling pathways. , 2011, Histology and histopathology.
[3] P. Delves,et al. Does hCG or hCGβ play a role in cancer cell biology? , 2010, Molecular and Cellular Endocrinology.
[4] R. Iles,et al. Gonadotropins and gonadotropin receptors—Evolutional genetics, signalling mechanisms, extra gonadal function and roles in oncogenesis , 2010, Molecular and Cellular Endocrinology.
[5] J. Guibourdenche,et al. Hyperglycosylated hCG is a marker of early human trophoblast invasion. , 2010, The Journal of clinical endocrinology and metabolism.
[6] L. Cole. Biological functions of hCG and hCG-related molecules , 2010, Reproductive biology and endocrinology : RB&E.
[7] L. Cole,et al. Hyperglycosylated hCG, a review. , 2010, Placenta.
[8] H. Verspaget,et al. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. , 2010, Cancer research.
[9] J. Foidart,et al. Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. , 2009, The Journal of clinical endocrinology and metabolism.
[10] L. Cole,et al. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters. , 2008, The Journal of reproductive medicine.
[11] L. Cole,et al. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. , 2008, Fertility and sterility.
[12] N. Bersinger,et al. Serum Hyperglycosylated Human Chorionic Gonadotropin to Predict the Gestational Outcome in in vitro Fertilization/Intracytoplasmic Sperm Injection Pregnancies , 2008, Fetal Diagnosis and Therapy.
[13] I. Laurendeau,et al. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. , 2007, Endocrinology.
[14] I. Laurendeau,et al. Human chorionic gonadotropin expression in human trophoblasts from early placenta: comparative study between villous and extravillous trophoblastic cells. , 2007, Placenta.
[15] T. Kakuma,et al. Hyperglycosylated HCG expression in pregnancy: Cellular origin and clinical applications , 2007, Molecular and Cellular Endocrinology.
[16] J. Foidart,et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] L. Cole,et al. Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. , 2006, The Journal of reproductive medicine.
[18] L. Cole,et al. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. , 2006, Gynecologic oncology.
[19] L. Cole,et al. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. , 2006, Gynecologic oncology.
[20] T. Libermann,et al. Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.
[21] C. White,et al. Cytokines, chemokines and growth factors in endometrium related to implantation. , 2005, Human reproduction update.
[22] T. Maruo,et al. Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. , 2005, The Journal of clinical endocrinology and metabolism.
[23] M. Goumans,et al. Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.
[24] T M Mayhew,et al. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. , 2004, Placenta.
[25] T M Mayhew,et al. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. , 2004, Placenta.
[26] K. Münstedt,et al. Angiogenesis and vasculogenesis in pregnancy. , 2003, European journal of obstetrics, gynecology, and reproductive biology.
[27] K. Preissner,et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. , 2002, The Journal of clinical endocrinology and metabolism.
[28] S. Robertson,et al. Defining the actions of transforming growth factor beta in reproduction , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[29] M. Maio,et al. Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies , 2001, Journal of cellular physiology.
[30] M. Diamond,et al. Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. , 2000, Placenta.
[31] S. Mathieu,et al. The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation , 2000, British Journal of Cancer.
[32] M. Goumans,et al. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. , 2000, The International journal of developmental biology.
[33] M. Goumans,et al. Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. , 1999, Development.
[34] K. McCrae,et al. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasivess and resistance to anti‐invasive action of TGFβ , 1998, International journal of cancer.
[35] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[36] L. Cole,et al. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. , 1997, Clinical chemistry.
[37] S. Lye,et al. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. , 1997, Endocrinology.
[38] M. Pepper,et al. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. , 1997, Cytokine & growth factor reviews.
[39] G. Owens,et al. Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. , 1996, Developmental biology.
[40] R. Berkowitz,et al. Gestational trophoblastic disease , 1995, Cancer.
[41] G. Owens,et al. Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.
[42] J. Irving,et al. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. , 1995, Experimental cell research.
[43] J. Spinnato,et al. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. , 1994, The Journal of clinical endocrinology and metabolism.
[44] D. C. Harris,et al. Crystal structure of human chorionic gonadotropin , 1994, Nature.
[45] W A Hendrickson,et al. Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. , 1994, Structure.
[46] H. Kliman,et al. Transforming growth factor-beta stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo. , 1994, The Journal of clinical endocrinology and metabolism.
[47] J. Környei,et al. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. , 1993, Biology of reproduction.
[48] M. Kan,et al. Bifunctional effects of transforming growth factor-β (TGF-β) on endothelial cell growth correlate with phenotypes of TGF-β binding sites , 1990 .
[49] L. Cole. HCG variants, the growth factors which drive human malignancies. , 2012, American journal of cancer research.
[50] I. Laurendeau,et al. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. , 2007, Endocrinology.
[51] L. Cole,et al. Hyperglycosylated hCG. , 2007, Placenta.
[52] Jean-Michel Foidart,et al. Improved quantification of angiogenesis in the rat aortic ring assay , 2004, Angiogenesis.
[53] Peter Berger,et al. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. , 2003, Clinical chemistry.
[54] H. M. Beier,et al. Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish implantation. , 2003, Reproductive biomedicine online.
[55] M. Poutanen,et al. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. , 2001, Molecular endocrinology.
[56] M. Kan,et al. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. , 1990, Experimental cell research.
[57] M. Ascoli. Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. , 1981, Endocrinology.